FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FRE - DE0005785604 - Common Stock
46.96 EUR
-0.61 (-1.28%)
Taking everything into account, FRE scores 4 out of 10 in our fundamental rating. FRE was compared to 29 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FRE get a neutral evaluation. Nothing too spectacular is happening here. FRE has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
FRE had positive earnings in the past year.
FRE had a positive operating cash flow in the past year.
FRE had positive earnings in 4 of the past 5 years.
FRE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 2.69%, FRE perfoms like the industry average, outperforming 55.17% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.14%, FRE is in line with its industry, outperforming 41.38% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.26%, FRE is doing worse than 68.97% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for FRE is below the industry average of 6.67%.
The last Return On Invested Capital (3.26%) for FRE is above the 3 year average (1.83%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 6.14% | ||
| ROIC | 3.26% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
1.3 Margins
The Profit Margin of FRE (5.11%) is better than 93.10% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
FRE's Operating Margin of 9.76% is amongst the best of the industry. FRE outperforms 89.66% of its industry peers.
FRE's Operating Margin has declined in the last couple of years.
FRE has a Gross Margin (24.99%) which is in line with its industry peers.
In the last couple of years the Gross Margin of FRE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.76% | ||
| PM (TTM) | 5.11% | ||
| GM | 24.99% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
FRE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for FRE has been reduced compared to a year ago.
2.2 Solvency
FRE has an Altman-Z score of 2.05. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.05, FRE is in line with its industry, outperforming 55.17% of the companies in the same industry.
FRE has a debt to FCF ratio of 11.28. This is a negative value and a sign of low solvency as FRE would need 11.28 years to pay back of all of its debts.
FRE's Debt to FCF ratio of 11.28 is on the low side compared to the rest of the industry. FRE is outperformed by 62.07% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
FRE has a better Debt to Equity ratio (0.61) than 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 11.28 | ||
| Altman-Z | 2.05 |
ROIC/WACC0.63
WACC5.2%
2.3 Liquidity
FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
FRE's Current ratio of 1.26 is fine compared to the rest of the industry. FRE outperforms 65.52% of its industry peers.
A Quick Ratio of 0.99 indicates that FRE may have some problems paying its short term obligations.
FRE has a better Quick ratio (0.99) than 62.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.74%, which is quite impressive.
Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
The Revenue has been growing slightly by 2.13% in the past year.
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
3.2 Future
Based on estimates for the next years, FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.63% on average per year.
The Revenue is expected to grow by 4.90% on average over the next years.
EPS Next Y13.2%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
EPS Next 5Y10.63%
Revenue Next Year4.46%
Revenue Next 2Y4.83%
Revenue Next 3Y4.85%
Revenue Next 5Y4.9%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.77 indicates a correct valuation of FRE.
FRE's Price/Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 79.31% of the companies in the same industry.
FRE is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.30, which indicates a correct valuation of FRE.
FRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 68.97% of the companies in the same industry.
FRE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.56.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.77 | ||
| Fwd PE | 12.3 |
4.2 Price Multiples
FRE's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, FRE is valued a bit more expensive than the industry average as 75.86% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.06 | ||
| EV/EBITDA | 10.33 |
4.3 Compensation for Growth
FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y12.64%
EPS Next 3Y11.7%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.09%, FRE has a reasonable but not impressive dividend return.
FRE's Dividend Yield is a higher than the industry average which is at 2.40.
FRE's Dividend Yield is comparable with the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.09% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
FRE pays out 59.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
FRA:FRE (12/9/2025, 5:36:15 PM)
46.96
-0.61 (-1.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners46.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.45B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts86.09
Price Target55.24 (17.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.09% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)5.66%
PT rev (3m)9.61%
EPS NQ rev (1m)-13.24%
EPS NQ rev (3m)-11.29%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)2.8%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.77 | ||
| Fwd PE | 12.3 | ||
| P/S | 1.18 | ||
| P/FCF | 22.06 | ||
| P/OCF | 12.15 | ||
| P/B | 1.42 | ||
| P/tB | 14.28 | ||
| EV/EBITDA | 10.33 |
EPS(TTM)3.41
EY7.26%
EPS(NY)3.82
Fwd EY8.13%
FCF(TTM)2.13
FCFY4.53%
OCF(TTM)3.87
OCFY8.23%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)1.04
PEG (5Y)N/A
Graham Number50.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 6.14% | ||
| ROCE | 6.63% | ||
| ROIC | 3.26% | ||
| ROICexc | 3.7% | ||
| ROICexgc | 8.63% | ||
| OM | 9.76% | ||
| PM (TTM) | 5.11% | ||
| GM | 24.99% | ||
| FCFM | 5.37% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 11.28 | ||
| Debt/EBITDA | 3.4 | ||
| Cap/Depr | 86.4% | ||
| Cap/Sales | 4.38% | ||
| Interest Coverage | 6.84 | ||
| Cash Conversion | 65.69% | ||
| Profit Quality | 104.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.05 |
F-Score7
WACC5.2%
ROIC/WACC0.63
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y13.2%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
EPS Next 5Y10.63%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.46%
Revenue Next 2Y4.83%
Revenue Next 3Y4.85%
Revenue Next 5Y4.9%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year66%
EBIT Next 3Y24.43%
EBIT Next 5Y15.57%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%
FRESENIUS SE & CO KGAA / FRE.DE FAQ
What is the ChartMill fundamental rating of FRESENIUS SE & CO KGAA (FRE.DE) stock?
ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.
What is the valuation status of FRESENIUS SE & CO KGAA (FRE.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for FRESENIUS SE & CO KGAA?
FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.
Can you provide the financial health for FRE stock?
The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.
Can you provide the dividend sustainability for FRE stock?
The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.